DePuy ASR Recall Settlement News: Federal Court Approves DePuy ASR Settlement Escrow Agreement, Bernstein Liebhard LLP Reports

• 

Our Firm is extremely pleased to see this matter moving forward, as we represent many DePuy ASR lawsuits plaintiffs who are qualified to participate in the settlement program.

New York, New York (PRWEB) May 24, 2014

The federal court overseeing thousands of DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) has approved an Escrow Agreement that establishes an Escrow Account and Sub-Accounts, as per the terms of the DePuy ASR settlement, Bernstein Liebhard LLP reports. According to an Order issued in the U.S. District Court, Northern District of Indiana, on May 21, 2014, the Court also appointed an escrow agent for the Common Benefit Fees and Expenses Fund, and set forth parameters for the payment of certain fees and expenses from that Sub-Account. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“Our Firm is extremely pleased to see this matter moving forward, as we represent many DePuy ASR lawsuits plaintiffs who are qualified to participate in the settlement program,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who may have been harmed by metal-on-metal hip implants, including those devices which were part of the 2010 DePuy ASR recall.

DePuy ASR Recall
Court documents indicate that more than 12,000 DePuy ASR lawsuits have been filed in state and federal courts around the country since Johnson & Johnson and DePuy Orthopaedics recalled the metal-on-metal hip implants in August 2010. The DePuy ASR settlement program, which was announced in November 2013, would resolve roughly 8,000 of those claims. In a Notice issued on May 20, 2014, the Court disclosed that a majority of eligible claimants have opted into the DePuy ASR settlement program, which will allow the agreement to move forward.

According to court records, plaintiffs qualified to participate in the DePuy ASR settlement include those who underwent revision surgery to replace their ASR hip due to a recall-related reason prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience "certain extraordinary injuries" in the future. Plaintiffs who do not wish to participate, or those who are not eligible, will still be permitted to pursue individual claims against DePuy Orthopaedics and Johnson & Johnson.

DePuy ASR hip recipients may be eligible to file suit against the manufacturers of the hip implant if they suffered metallosis, pain, pseudotumor formation, premature device failure or other complications allegedly related to its metal-on-metal design. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP's website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State's contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm's fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff's recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author

PDF Print